# Indivior Pharmaceuticals, Inc. (INDV) FY2026 Q3 Balance Sheet

- Company: Indivior Pharmaceuticals, Inc. (INDV)
- Period: As of 2026-09-30
- Filing: Q3 FY2026 10-Q, filed 2026-10-29, accession number 0001628280-26-068013
- Page: https://plicit.ai/financials/indv/fy2026-q3-balance-sheet
- Chart image: https://plicit.ai/charts/indv-fy2026-q3-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-09-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 1,332,000,000 US dollars
- **Current assets**: 800,000,000 US dollars
- **Non-current assets**: 532,000,000 US dollars
- **Liabilities**: 1,392,000,000 US dollars
- **Current liabilities**: 1,301,000,000 US dollars
- **Non-current liabilities**: 91,000,000 US dollars
- **Shareholders' deficit**: negative 60,000,000 US dollars
- **Cash and cash equivalents**: 305,000,000 US dollars
- **Accounts receivable, net of allowances of $3 (2026) and $4 (2025)**: 273,000,000 US dollars
- **Inventories**: 149,000,000 US dollars
- **Other current assets**: 40,000,000 US dollars
- **Prepaid expenses**: 21,000,000 US dollars
- **Current tax receivable**: 13,000,000 US dollars
- **Deferred tax assets**: 288,000,000 US dollars
- **Property, plant and equipment, net**: 175,000,000 US dollars
- **Long-term investments**: 27,000,000 US dollars
- **Other noncurrent assets**: 27,000,000 US dollars
- **Operating lease right of use assets, net**: 12,000,000 US dollars
- **Goodwill and other intangible assets, net**: 2,000,000 US dollars
- **Accrued rebates and product returns**: 548,000,000 US dollars
- **Current portion of long-term debt**: 488,000,000 US dollars
- **Accounts payable and accrued expenses**: 181,000,000 US dollars
- **Income taxes payable**: 63,000,000 US dollars
- **Accrued litigation settlement expenses, current**: 14,000,000 US dollars
- **Operating lease liabilities, current**: 7,000,000 US dollars
- **Accrued litigation settlement expenses, noncurrent**: 42,000,000 US dollars
- **Other noncurrent liabilities**: 42,000,000 US dollars
- **Operating lease liabilities, noncurrent**: 6,000,000 US dollars
- **Long-term debt, less current portion**: 0 US dollars
- **Additional paid-in capital**: 163,000,000 US dollars
- **Common stock, par value $0.001 per share (2026) and $0.50 per share (2025). Issued shares: 118 (2026) and 125 (2025)**: 0 US dollars
- **Accumulated deficit**: negative 197,000,000 US dollars
- **Accumulated other comprehensive loss**: negative 26,000,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.
- The filed current assets lines add up to $801.00 M and the current assets total is $800.00 M; the $1.00 M difference is within the rounding of the filed amounts.
- The filed non-current assets lines add up to $531.00 M and the non-current assets total is $532.00 M; the $1.00 M difference is within the rounding of the filed amounts.
- The filed non-current liabilities lines add up to $90.00 M and the non-current liabilities total is $91.00 M; the $1.00 M difference is within the rounding of the filed amounts.
